Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP. Teunissen JJ, et al. Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. doi: 10.1530/ERC-10-0282. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 22005114 Review.
Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.
Zandee WT, Brabander T, Blažević A, Kam BLR, Teunissen JJM, Feelders RA, Hofland J, de Herder WW. Zandee WT, et al. Among authors: teunissen jjm. J Clin Endocrinol Metab. 2019 Apr 1;104(4):1336-1344. doi: 10.1210/jc.2018-01991. J Clin Endocrinol Metab. 2019. PMID: 30566620
Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
Braat AJAT, Kwekkeboom DJ, Kam BLR, Teunissen JJM, de Herder WW, Dreijerink KMA, van Rooij R, Krijger GC, de Jong HWAM, van den Bosch MAAJ, Lam MGEH. Braat AJAT, et al. Among authors: teunissen jjm. BMC Gastroenterol. 2018 Jun 15;18(1):84. doi: 10.1186/s12876-018-0817-8. BMC Gastroenterol. 2018. PMID: 29902988 Free PMC article. Clinical Trial.
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Bergsma H, van Lom K, Raaijmakers MHGP, Konijnenberg M, Kam BLBLR, Teunissen JJM, de Herder WW, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: teunissen jjm. J Nucl Med. 2018 Mar;59(3):452-458. doi: 10.2967/jnumed.117.189712. Epub 2017 Aug 3. J Nucl Med. 2018. PMID: 28775205 Free article.
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jjm. Clin Cancer Res. 2017 Aug 15;23(16):4617-4624. doi: 10.1158/1078-0432.CCR-16-2743. Epub 2017 Apr 20. Clin Cancer Res. 2017. PMID: 28428192 Free article.
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, de Herder WW, Feelders RA, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jjm. Endocr Relat Cancer. 2017 May;24(5):243-251. doi: 10.1530/ERC-16-0524. Epub 2017 Mar 20. Endocr Relat Cancer. 2017. PMID: 28320783
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11. doi: 10.1007/s00259-016-3382-9. Epub 2016 May 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 27160225 Free PMC article.
Peptide receptor radionuclide therapy of neuroendocrine tumours.
Brabander T, Teunissen JJ, Van Eijck CH, Franssen GJ, Feelders RA, de Herder WW, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jj. Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):103-14. doi: 10.1016/j.beem.2015.10.005. Epub 2015 Oct 8. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971847 Review.
Subacute haematotoxicity after PRRT with (177)Lu-DOTA-octreotate: prognostic factors, incidence and course.
Bergsma H, Konijnenberg MW, Kam BL, Teunissen JJ, Kooij PP, de Herder WW, Franssen GJ, van Eijck CH, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):453-63. doi: 10.1007/s00259-015-3193-4. Epub 2015 Sep 30. Eur J Nucl Med Mol Imaging. 2016. PMID: 26419852 Free PMC article.
Nuclear Medicine Imaging of Neuroendocrine Tumors.
Brabander T, Kwekkeboom DJ, Feelders RA, Brouwers AH, Teunissen JJ. Brabander T, et al. Front Horm Res. 2015;44:73-87. doi: 10.1159/000382059. Epub 2015 Aug 14. Front Horm Res. 2015. PMID: 26303705 Review.
41 results
Jump to page
Feedback